role of rebates in glp-1 pbm decisions What to Know About Pharmacy Benefit Managers (PBMs) and Federal Efforts at Regulation PBM Regulations on Drug Spending

Glucagon-like peptide-1 (GLP-1) agonists are very popular and useful medications for the treatment of type 2 diabetes mellitus and obesity

Credit: Joanna Sadowska, PhD, EMBA !

Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects...

Active individuals

Bridging the gap between clinical potential and real-world impact enables stakeholders to decode the complex interplay of these forces and rethink what it truly takes to keep patients on the path to sustained outcomes

Obesity has become a major global health crisis impacting every corner of the world, with some of the most rapid increases in prevalence seen in low- and middle-income countries